Pharmacogenomics of Drug Response in Type 2 Diabetes: Toward the Definition of Tailored Therapies?
Type 2 diabetes is one of the major causes of mortality with rapidly increasing prevalence. Pharmacological treatment is the first recommended approach after failure in lifestyle changes. However, a significant number of patients shows—or develops along time and disease progression—drug resistance....
Saved in:
| Main Authors: | Carla Pollastro, Carmela Ziviello, Valerio Costa, Alfredo Ciccodicola |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2015-01-01
|
| Series: | PPAR Research |
| Online Access: | http://dx.doi.org/10.1155/2015/415149 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pharmacogenomics in Renal Transplantation: Tailoring Tacrolimus for Enhanced Patient Outcomes
by: Vikash Chandra Mishra, et al.
Published: (2025-01-01) -
Dynamic star allele definitions in Pharmacogenomics: impact on diplotype calls, Phenotype predictions and statin therapy recommendations
by: Sven van der Maas, et al.
Published: (2025-05-01) -
Influence of OCT2 gene variants on metformin efficacy in type 2 diabetes: insights into pharmacogenomics and drug interactions
by: Ma’mon M. Hatmal, et al.
Published: (2025-08-01) -
Unveiling Pharmacogenomics Insights into Circular RNAs: Toward Precision Medicine in Cancer Therapy
by: Saud Alqahtani, et al.
Published: (2025-04-01) -
Pharmacogenomics
by: M S Shivashankara
Published: (2020-01-01)